Clinical Trial Update: A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy and safety of Empasiprubart versus intravenous immunoglobulin in adults with Multifocal Motor Neuropathy; enrollment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multifocal Motor Neuropathy

Drugs mentioned

• Empasiprubart
• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: argenx | Conditions: Multifocal Motor Neuropathy (MMN), MMN | Phase 3 | Status: RECRUITING